These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3105441)

  • 1. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid.
    Casal MJ; Rodriguez FC; Luna MD; Benavente MC
    Antimicrob Agents Chemother; 1987 Jan; 31(1):132-3. PubMed ID: 3105441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium kansasii to amoxycillin and ticarcillin in combination with clavulanic acid.
    Wong CS; Palmer GS; Cynamon MH
    J Antimicrob Chemother; 1988 Dec; 22(6):863-6. PubMed ID: 3149633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of ticarcillin plus clavulanic acid (BRL 28500, 'Timentin') against ticarcillin-resistant gram-negative rods.
    Chattopadhyay B; Hall I
    Curr Med Res Opin; 1984; 9(3):157-60. PubMed ID: 6568146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin.
    Casal M; Rodriguez F; Benavente M; Luna M
    Eur J Clin Microbiol; 1986 Aug; 5(4):453-4. PubMed ID: 3093225
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.
    Fuchs PC; Barry AL; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1984 Mar; 25(3):392-4. PubMed ID: 6721472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro activity of the combination ticarcillin-clavulanic acid on bacterial isolates in surgery].
    Branger C; Kitzis M; Le Mée J
    Pathol Biol (Paris); 1986 Apr; 34(4):245-8. PubMed ID: 3528998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of ticarcillin-resistant gram-negative bacilli to different combinations of ticarcillin and clavulanic acid.
    Verbist L; Verhaegen J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():7-15. PubMed ID: 3636338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosa.
    Manian FA; Alford RH
    Antimicrob Agents Chemother; 1986 Jul; 30(1):35-8. PubMed ID: 3092732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1984 Apr; 19(4):555-7. PubMed ID: 6715524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
    Thomas L; Naumann P; Crea A
    Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study.
    Fuchs PC; Jones RN; Barry AL; Allen SD; Aldridge KE; Gerlach EH; Sommers HM
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):47-50. PubMed ID: 3370931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of clavulanic acid, amoxicillin, and ticarcillin against Chlamydia trachomatis.
    Bowie WR
    Antimicrob Agents Chemother; 1986 Apr; 29(4):713-5. PubMed ID: 3707116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
    Rotstein C; Amsterdam D; Beam T; Gorzynski E
    Diagn Microbiol Infect Dis; 1989; 12(2):157-63. PubMed ID: 2752713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers.
    Barry AL; Ayers LW; Gavan TL; Gerlach EH; Jones RN
    Eur J Clin Microbiol; 1984 Jun; 3(3):203-6. PubMed ID: 6147246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
    Bansal MB; Chuah SK; Oryema-Lalobo M; Thadepalli H
    Chemotherapy; 1985; 31(3):173-7. PubMed ID: 3996086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activity of ticarcillin in combination with clavulanic acid against Bacteroides species: an in-vitro comparison with other antibiotics.
    de Barbeyrac B; Quentin C; Bébéar C
    J Antimicrob Chemother; 1986 May; 17 Suppl C():35-9. PubMed ID: 3636337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antistaphylococcal activity of amoxicillin and ticarcillin when combined with clavulanic acid. Evaluation of oxacillin-resistant and oxacillin-susceptible isolates.
    Barry AL
    Diagn Microbiol Infect Dis; 1990; 13(5):357-61. PubMed ID: 2282775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1984 Feb; 13(2):121-8. PubMed ID: 6323375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
    Texier-Maugein J; Mormède M; Fourche J; Bébéar C
    Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.